Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GLOFITAMAB-GXBM: Who Reports Side Effects? Age, Gender & Country Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Gender Distribution

36.2%
Female
63.8%
Male

Age Information

The average age of patients reporting adverse events with GLOFITAMAB-GXBM is 60.0 years.

Geographic Distribution

The majority of adverse event reports for GLOFITAMAB-GXBM originate from CN.

Report Summary & Outcomes

498
Total Reports
498
As Primary/Secondary Suspect
175
Deaths Reported
113
Hospitalizations
24
Life-Threatening
5
Disabilities

Reporting Timeline

First adverse event report: 20180601. Most recent report: 20250915. View full timeline →

More About GLOFITAMAB-GXBM

GLOFITAMAB-GXBM Full Profile Reports by Year Drug Interactions